LRMR (STOCKS)
Larimar Therapeutics, Inc. Common Stock
$3.210000
-0.130000 (-3.89%)
Prev close: $3.340000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Carole S. Ben-Maimon
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $273.03M
- Employees
- 65
- P/E (TTM)
- -1.67
- P/B (TTM)
- 2.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.61 | $-0.41 | -0.1979 | -48.02% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.49 | +0.0798 | +16.29% |
|
Mar 2025 (Q1)
|
$-0.46 | $-0.43 | -0.0334 | -7.83% |
|
Dec 2024 (Q4)
|
$-0.45 | $-0.32 | -0.1266 | -39.15% |